Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MOHAMMAD M JAMIL

Allopathic & Osteopathic Physicians Thoracic Surgery (Cardiothoracic Vascular Surgery)

NPI
1679880025
CMS profile
1122927
Location
JOHNSON CITY, NY

General Payments · PY2018–2024

$6,103.90

  • Reported across 118 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$577.76

31 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $577.76 31

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $273.15 24
Edwards Lifesciences Corporation $145.47 3
ATRICURE, INC. $91.63 1
ABIOMED $26.74 1
Amgen Inc. $22.17 1
Daiichi Sankyo Inc. $18.60 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $285.59 9
PY2019 $12.85 1
PY2020 $307.25 2
PY2021 $521.54 6
PY2022 $3,506.35 31
PY2023 $892.56 38
PY2024 $577.76 31

Payment records · PY2024 (31)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABIOMED $26.74 09/18/2024 Food and Beverage Undisputed 01/23/2026 1142229307 CMS
Amgen Inc. $22.17 02/01/2024 Food and Beverage Undisputed 01/23/2026 1115760434 CMS
ATRICURE, INC. $91.63 02/27/2024 Food and Beverage Undisputed 01/23/2026 1132867330 CMS
Daiichi Sankyo Inc. $18.60 05/13/2024 Food and Beverage Undisputed 01/23/2026 1089437387 CMS
Edwards Lifesciences Corporation $27.97 04/17/2024 Food and Beverage Undisputed 01/23/2026 1138801704 CMS
Edwards Lifesciences Corporation $100.34 10/09/2024 Food and Beverage Undisputed 01/23/2026 1138801714 CMS
Edwards Lifesciences Corporation $17.16 11/13/2024 Food and Beverage Undisputed 01/23/2026 1138801718 CMS
Novartis Pharmaceuticals Corporation $11.60 01/16/2024 Food and Beverage Undisputed 01/23/2026 1086977686 CMS
Novartis Pharmaceuticals Corporation $9.38 01/16/2024 Food and Beverage Undisputed 01/23/2026 1086977692 CMS
Novartis Pharmaceuticals Corporation $11.34 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086977688 CMS
Novartis Pharmaceuticals Corporation $9.01 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086977694 CMS
Novartis Pharmaceuticals Corporation $9.38 02/14/2024 Food and Beverage Undisputed 01/23/2026 1086977690 CMS
Novartis Pharmaceuticals Corporation $12.99 02/14/2024 Food and Beverage Undisputed 01/23/2026 1086977696 CMS
Novartis Pharmaceuticals Corporation $10.61 03/06/2024 Food and Beverage Undisputed 01/23/2026 1086977702 CMS
Novartis Pharmaceuticals Corporation $11.04 03/06/2024 Food and Beverage Undisputed 01/23/2026 1086977704 CMS
Novartis Pharmaceuticals Corporation $13.14 04/01/2024 Food and Beverage Undisputed 01/23/2026 1086977710 CMS
Novartis Pharmaceuticals Corporation $11.78 04/01/2024 Food and Beverage Undisputed 01/23/2026 1086977712 CMS
Novartis Pharmaceuticals Corporation $9.35 04/30/2024 Food and Beverage Undisputed 01/23/2026 1086977714 CMS
Novartis Pharmaceuticals Corporation $9.94 04/30/2024 Food and Beverage Undisputed 01/23/2026 1086977716 CMS
Novartis Pharmaceuticals Corporation $12.86 05/20/2024 Food and Beverage Undisputed 01/23/2026 1086977720 CMS
Novartis Pharmaceuticals Corporation $14.33 05/20/2024 Food and Beverage Undisputed 01/23/2026 1086977726 CMS
Novartis Pharmaceuticals Corporation $13.79 05/28/2024 Food and Beverage Undisputed 01/23/2026 1086977722 CMS
Novartis Pharmaceuticals Corporation $11.12 05/28/2024 Food and Beverage Undisputed 01/23/2026 1086977728 CMS
Novartis Pharmaceuticals Corporation $13.95 06/10/2024 Food and Beverage Undisputed 01/23/2026 1086977724 CMS
Novartis Pharmaceuticals Corporation $11.31 06/10/2024 Food and Beverage Undisputed 01/23/2026 1086977730 CMS
Novartis Pharmaceuticals Corporation $10.62 07/29/2024 Food and Beverage Undisputed 01/23/2026 1086977738 CMS
Novartis Pharmaceuticals Corporation $11.43 07/29/2024 Food and Beverage Undisputed 01/23/2026 1086977740 CMS
Novartis Pharmaceuticals Corporation $10.69 08/28/2024 Food and Beverage Undisputed 01/23/2026 1086977744 CMS
Novartis Pharmaceuticals Corporation $12.05 10/21/2024 Food and Beverage Undisputed 01/23/2026 1086977746 CMS
Novartis Pharmaceuticals Corporation $11.20 10/21/2024 Food and Beverage Undisputed 01/23/2026 1086977748 CMS
Novartis Pharmaceuticals Corporation $10.24 12/16/2024 Food and Beverage Undisputed 01/23/2026 1086977754 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.